Drug Trial Radar · NCT06943755
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
440
Planned (sponsor's estimate)
Start
Jul 21, 2025
Primary completion
Jun 30, 2029
Study completion Jun 30, 2029
Sponsor
- Lead sponsor
- ExelixisIndustry
- Sponsor type
- Industry
- First posted
- Apr 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to assess the effectiveness of zanzalintinib compared to everolimus in participants with previously treated, unresectable, locally advanced or metastatic neuroendocrine tumors.
Conditions
- Pancreatic Neuroendocrine Tumor (pNET)
- Extra-Pancreatic Neuroendocrine Tumor (epNET)
Interventions
ZanzalintinibDrug
Administered as specified in the treatment arm.
EverolimusDrug
Administered as specified in the treatment arm.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-Free Survival (PFS) Per Response Evaluation Criteria in Solid Tumors Version (RECIST) 1.1 as Assessed by Blinded Independent Central Review (BICR)Time frame: Up to 48 months
Locations
135 sites in 18 countries. Site status is shown where the registry gives one.
The University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
Mayo Clinic Hospital
Phoenix, Arizona · Recruiting
The University of Arizona Cancer Center
Tucson, Arizona · Recruiting
Cedars-Sinai Medical Center
Beverly Hills, California · Recruiting
Norris Comprehensive Cancer Center
Los Angeles, California · Recruiting
Stanford Cancer Center
Palo Alto, California · Recruiting
UCLA Health - Santa Monica Cancer Care
Santa Monica, California · Recruiting
Kaiser Permanente Medical Center
Vallejo, California · Recruiting
Georgetown University
Washington D.C., District of Columbia · Recruiting
Mayo Clinic - Florida
Jacksonville, Florida · Recruiting
AdventHealth Orlando
Orlando, Florida · Recruiting
Moffitt Cancer Center
Tampa, Florida · Recruiting
University of Kentucky Markey Cancer Center
Lexington, Kentucky · Recruiting
East Jefferson General Hospital
Metairie, Louisiana · Recruiting
National Institute of Health
Bethesda, Maryland · Recruiting
Dana-Farber Cancer Institute
Boston, Massachusetts · Recruiting
Henry Ford Cancer- Detroit
Detroit, Michigan · Recruiting
The Cancer and Hematology Centers
Grand Rapids, Michigan · Recruiting
Mayo Clinic
Rochester, Minnesota · Recruiting
Siteman Cancer Center
St Louis, Missouri · Recruiting
University of Nebraska Medical Center
Omaha, Nebraska · Recruiting
University of New Mexico Comprehensive Cancer Center
Albuquerque, New Mexico · Recruiting
Roswell Park Cancer Institute
Buffalo, New York · Recruiting
Icahan School of Medicine at Mount Sinai
New York, New York · Recruiting
University of Rochester Medical Center
Rochester, New York · Recruiting
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina · Recruiting
Duke University Medical Center
Durham, North Carolina · Recruiting
Sanford Roger Maris Cancer Center
Fargo, North Dakota · Recruiting
University Hospitals Cleveland Medical Center
Cleveland, Ohio · Recruiting
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio · Recruiting
Oregon Health and Science University
Portland, Oregon · Recruiting
University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center
Pittsburgh, Pennsylvania · Recruiting
University of Tennessee Medical Center
Knoxville, Tennessee · Recruiting
Henry-Joyce Cancer Clinic
Nashville, Tennessee · Recruiting
Texas Oncology- Baylor Charles A. Sammons Cancer Center
Dallas, Texas · Recruiting
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah · Recruiting
University of Virginia
Charlottesville, Virginia · Recruiting
Virginia Cancer Specialists - Fairfax Office
Fairfax, Virginia · Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington · Recruiting
Showing 40 of 135 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.